*ST Suwu: Faces multiple risks of delisting including major violations leading to forced delisting, financial delisting, and nominal value delisting.

Announcement of abnormal fluctuations in ST Suwu stock trading: The closing price of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. stock has deviated by more than 12% for three consecutive trading days, indicating abnormal fluctuations in stock trading. The recent price increase of the company's stock is significant, with the stock price deviating significantly from fundamentals, possibly due to market sentiment overheating and irrational speculation, accumulating significant trading risks and the risk of a rapid decline at any time. The company faces multiple risks of forced delisting for major violations, financial delisting, face value delisting, etc. There are also operational risks such as unresolved significant capital occupation by the controlling shareholder, freezing of all shares held by the controlling shareholder, and uncertainty in the arbitration results of the exclusive agency rights for medical beauty products.